University Hospitals Plymouth NHS Trust

Specialist MDT: Plymouth Hospitals NHS Trust

View Provider Services

Men diagnosed at this hospital trust can access the following services:

  • Diagnostic Facilities:
    • Multiparametric MRI
    • Transperineal biopsy under local anaesthetic
    • Transperineal biopsy under general anaesthetic
    • Choline PET
    • Isotope bone scan
    • One-stop diagnostic clinic
  • Treatment Facilities:
    • Radical prostatectomy
    • Robot assisted laparoscopic prostatectomy
    • External beam radiotherapy (EBRT)
    • Stereotactic body radiation therapy (SBRT)
    • Chemotherapy
  • Support Service Facilities:
    • Clinical Nurse Specialist (CNS) in all clinics
    • Prostate cancer-specific CNSs
    • Advanced PCa CNS
    • Urology CNS
    • Sexual function services
    • Specialist continence services

Data Quality

For Wales, this data completeness relates to patients diagnosed between April 2022 and March 2023.
For England, this data completeness relates to patients diagnosed in 2021. This is the data completeness of the National Cancer Registration Dataset (NCRD). For data completeness of the Rapid Cancer Registration Dataset (RCRD), please refer to the NPCA quarterly reports.

Diagnosing Trust Specialist MDT
No. of Cancer Registry records 401 779
Performance Status recorded 81% 84%
PSA completed 3% 46%
Gleason Score completed 82% 78%
TNM completed 82% 77%

Disease Presentation

For Wales, these results relate to patients diagnosed between April 2022 and March 2023.
For England, these results relate to patients diagnosed between January and December 2021.

Specialist MDT National
No. of men with disease status determined 762 39897
Percentage of men diagnosed with metastatic disease 22% 17%

Management

For Wales, these results relate to patients diagnosed between April 2022 and March 2023.
For England, these results relate to patients diagnosed between January and December 2021.

Specialist MDT National
No. of men diagnosed with low-risk localised disease 66 4684
Percentage of men with low-risk localised disease receiving radical treatment 0% 8%
No. of men diagnosed with locally advanced disease 304 15410
Percentage of men diagnosed with locally advanced disease receiving radical treatment 64% 68%

Outcome

Treatment Centre
No. of men who received radical prostatectomy (April 2022- March 2023) 134
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%) 8%
No. of men who received radical prostatectomy (September 2020 - August 2021) 61
Adjusted percentage of men experiencing at least one GU complication (%) 0%
No. of men who received radical radiotherapy (September 2020 - August 2021) 139
Adjusted percentage of men experiencing at least one GI complication (%) 8%

Compare provider outcomes